Kyverna Therapeutics, Inc. (KYTX)
NASDAQ·Healthcare·Biotechnology
$8.32
+5.18%
Mkt Cap $356.90M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$30.75
Range $25.00 – $33.00
Implied Upside
+269.6%
Consensus $30.75 vs current $8.32
NASDAQ·Healthcare·Biotechnology
$8.32
+5.18%
Mkt Cap $356.90M
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$30.75
Range $25.00 – $33.00
+269.6%
Consensus $30.75 vs current $8.32